tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ami Fadia, 504 are a BUY (89.84%), 52 are a HOLD (9.27%), 5 are a SELL (0.89%).
Analyst Ami Fadia, currently employed at NEEDHAM, carries an average stock price target met ratio of 49.67% that have a potential upside of 36.63% achieved within 185 days.
Ami Fadia’s has documented 1,085 price targets and ratings displayed on 43 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on ACAD, ACADIA Pharmaceuticals at 19-Oct-2026.
Analyst best performing recommendations are on PRAX (PRAXIS PRECISION MEDICINES).
The best stock recommendation documented was for RVMD (REVOLUTION MEDICINES) at 10/12/2023. The price target of $34 was fulfilled within 4 days with a profit of $9.8 (40.5%) receiving and performance score of 101.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 06-Jun-2022
$13
$1.21 (10.26%)
2 months 5 days ago
(21-Aug-2026)
2/4 (50%)
$-1.09 (-7.74%)
170
Hold Since 19-Oct-2022
$12
$-3.91 (-24.58%)
$800
11 months 25 days ago
(30-Oct-2025)
2/4 (50%)
$-4.4 (-26.83%)
1055
Sell Since 03-Nov-2021
$12
$0.21 (1.78%)
$20
1 years 4 months 1 days ago
(25-Jun-2025)
10/14 (71.43%)
$-4.19 (-25.88%)
92
Buy Since 05-Mar-2021
$100
2 years 4 months 6 days ago
(20-Jun-2024)
12/56 (21.43%)
$62.4 (165.96%)
171
Buy Since 25-Oct-2023
$20
$8.21 (69.64%)
$60
3 years 1 days ago
(25-Oct-2023)
5/26 (19.23%)
$5.72 (40.06%)
73
Which stock is Ami Fadia most bullish on?
Which stock is Ami Fadia most reserved on?
What Year was the first public recommendation made by Ami Fadia?
